MoxifloxacinAcquired drug resistance: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1912卷 / 1期

关键词：

D O I：

10.1007/s40278-022-18005-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：302 / 302

相关论文

共 50 条

[1] MoxifloxacinAcquired drug resistance: case report
Reactions Weekly, 2020, 1835 (1) : 261 - 261
[2] AntineoplasticsAcquired drug resistance: 5 case reports
Reactions Weekly, 2022, 1910 (1) : 53 - 53
[3] Ceftolozane/tazobactamDevelopment of drug resistance: 5 case reports
Reactions Weekly, 2021, 1840 (1) : 114 - 114
[4] Avibactam/ceftazidimeDevelopment of drug resistance: 5 case reports
Reactions Weekly, 2021, 1863 (1) : 63 - 63
[5] Antibacterial drugsAcquired drug resistance: 5 case reports
Reactions Weekly, 2022, 1937 (1) : 44 - 44
[6] DaclatasvirHCV relapse due to drug resistance: 5 case reports
Reactions Weekly, 2017, 1641 (1) : 102 - 102
[7] Antituberculars/antibacterialsVarious toxicities and drug resistance: 5 case reports
Reactions Weekly, 2020, 1785 (1) : 76 - 76
[8] AntiviralsEmergence of drug resistance and lack of efficacy: 5 case reports
Reactions Weekly, 2021, 1877 (1) : 46 - 46
[9] Crizotinib/savolitinibAcquired drug resistance and lack of efficacy: 5 case reports
Reactions Weekly, 2022, 1915 (1) : 154 - 154
[10] IbrutinibAcquired drug resistance following lack of efficacy: 5 case reports
Reactions Weekly, 2021, 1876 (1) : 161 - 161

← 1 2 3 4 5 →